FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $121,000 | -2.4% | 24,100 | 0.0% | 0.05% | -34.2% |
Q1 2018 | $124,000 | -14.5% | 24,100 | 0.0% | 0.07% | +19.7% |
Q4 2017 | $145,000 | +8.2% | 24,100 | 0.0% | 0.06% | +56.4% |
Q3 2017 | $134,000 | +19.6% | 24,100 | 0.0% | 0.04% | -11.4% |
Q2 2017 | $112,000 | -47.4% | 24,100 | -44.0% | 0.04% | -30.2% |
Q1 2017 | $213,000 | -86.0% | 43,000 | -68.6% | 0.06% | -88.7% |
Q4 2016 | $1,521,000 | +19.9% | 137,000 | 0.0% | 0.56% | +44.9% |
Q3 2016 | $1,269,000 | +95.8% | 137,000 | +34.3% | 0.38% | +40.0% |
Q2 2016 | $648,000 | -2.6% | 102,000 | 0.0% | 0.28% | -8.9% |
Q1 2016 | $665,000 | -19.6% | 102,000 | 0.0% | 0.30% | -13.5% |
Q4 2015 | $827,000 | +10.6% | 102,000 | 0.0% | 0.35% | -18.3% |
Q3 2015 | $748,000 | – | 102,000 | – | 0.43% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|